Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies episode artwork

EPISODE · Feb 14, 2023 · 1H 11M

Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

from The Long Run with Luke Timmerman · host Timmerman Report

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.

NOW PLAYING

Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

0:00 1:11:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 11 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on February 14, 2023.

What is this episode about?

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!